top of page

Jennifer Slepin is a hepatitis C activist and educator.  She holds a Master of Science in Nursing with a focus on Outcomes Management from the School of Nursing at the University of North Carolina at Chapel Hill.   

After being infected with the hepatitis C virus for over 30 years, she was CURED in May of 2016.  Compelled to learn who she would be without hepatitis C, she set out on a solo cross-country camping trip in June of 2016, to raise awareness and to learn about how communities are coping with the hepatitis C epidemic.  

That 6 month road trip resulted in the formation of HepCarestream aka Hepatitis C Clinical Education Group, Inc., a 501(c)3 nonprofit organization committed to actively working at a grassroots level in underserved communities to educate primary care providers to treat hepatitis C.   This clinical education is provided as part of UCSF's Hepatitis C Project ECHO hub, via videoconferencing technology.  


The organization purchased a used Airstream now known as the HepCarestream and in January 2018 Jennifer set out to take the ECHO learning opportunity into 13 rural Northern California counties, understanding that culturally sensitive and community specific support toward HCV elimination can really only be cultivated from within a community.  

our Founder

Jennifer Slepin, MSN, RN, PHN

HepCarestream is a nurse run company working to end the hepatitis C epidemic through empathetic advocacy, education, and presence in medically underserved areas.

Our Distinguished Board

Norah Terrault, MD, MPH


Dr. Norah Terrault is a Professor of Medicine and the Director of the Viral Hepatitis Center at the University of California San Francisco. 

She is recognized nationally and internationally for her work related to viral hepatitis, especially in the setting of liver transplantation.  She has authored more than 275 original articles, reviews and book chapters. She has served as Associate Editor for Hepatology and Deputy Editor for Liver Transplantation in the recent past and is current Associate Editor for Hepatology Communications. She is an investigator on several NIH-funded clinical studies in hepatitis B and NASH and is an investigator on several ongoing clinical trials of therapies for patients with chronic hepatitis B, hepatitis C and NASH.


Lisa Catalli, MSN, NP-C 


Lisa Catalli earned her Master’s Degree from UCSF Nursing School and was trained as a Registered Nurse and Adult Nurse Practitioner with specializations in HIV and cross-cultural nursing.   Over the past 8 years at UCSF, she has been working across the liver disease spectrum with special focus on Hepatitis C, including patients pre- and post-liver transplantation.  She is a Faculty Speaker/ Mentor for the UCSF HCV Project ECHO Program and partners with community providers to provide greater access care to patients with HCV and liver disease. She is co-investigator with Dr. Norah Terrault for multiple clinical trials at UCSF and is a member of the American Association of the Study of Liver Diseases.

Carol Brosgart, MD 


Carol L. Brosgart, M.D., serves on the Steering Committee of the National Viral Hepatitis Roundtable, the Executive Committee of the Forum for Collaborative Research, and the Steering Committee of the HBV Cure Group at the Forum. She served for many years on the Boards of the SF AIDS Foundation and the Pangaea Global AIDS Foundation. She is active in the public policy arena for AASLD and IDSA/HIVMA.  Dr. Brosgart served as Senior Advisor on Science and Policy to the Division of Viral Hepatitis at the CDC and to the Viral Hepatitis Action Coalition at the CDC Foundation from 2011 to 2013. Dr. Brosgart has also served as a member on the faculty of the School of Medicine at the University of California, San Francisco for the past three decades, where she is a Clinical Professor of Medicine, Biostatistics and Epidemiology in the Division of Global Health and Infectious Diseases. Dr. Brosgart worked for more than 20 years in clinical care, research and teaching at several Bay Area medical centers. S

Brandie Wilson Headshot.jpg

Brandie Wilson, MS

Pierre Professional Picture.jpg

Pierre Cedric-Crouch, PhD, ANP-BC, ACRN

Pierre has been working as a nurse in HIV and sexual healthcare for 20 years. In his career, he developed and implemented one of the largest nurse-led PrEP Health Programs, a novel Hep C treatment program in a syringe access center, the first PrEP 211/On Demand program in the USA, rapid HIV treatment initiations and rapid HIV treatment re-engagement programs, express STI testing,  and enhanced point of care laboratory technologies.  He champions RN-delivered care, which supports nurses practicing to the fullest extent of their license and taking a client-centered approach to remove traditional barriers to accessing healthcare. He grew up in New Orleans, Louisiana where he obtained his BSN from the Louisiana State University Health Science Center. He received his MSN (Nurse Practitioner) and PhD from the University of California, San Francisco.

Brandie Wilson is a Harm Reduction Professional who has been impacted by the War on Drugs since the age of 13. Her lived experience created many opportunities wherein there were no safe spaces to discuss the realities of drug use. Her personal situation combined with the public war on drugs effectively ostracized her from her family and community and resulted in her living on the streets in Nevada. During this time Brandie had endured the criminal Justice System due to drug use as well participating in survival sex work. After years of struggle she was able to enter college and change the path of her existence with massive support from friends who had walked the same path years before. She has since obtained a Masters Degree in Sociology from Humboldt State University, founded Humboldt Area Center for Harm Reduction, and is currently the Executive Director for Chicago Recovery Alliance. Brandie uses her experiences and education to reach people who, like her, have had their lives decimated by the War on Drugs and are now learning to heal self and community. 



Read More >


Read More >





bottom of page